SEARCH

SEARCH BY CITATION

Keywords:

  • challenge hypothesis;
  • cross-cultural variation;
  • male reproductive physiology;
  • prostate cancer;
  • testosterone

Abstract

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

An accumulation of evidence suggests that increased exposure to androgens is associated with prostate cancer risk. The unrestricted energy budget that is typical of Western diets represents a novel departure from the conditions in which men's steroid physiology evolved and is capable of supporting distinctly elevated testosterone levels. Although nutritional constraints likely underlie divergent patterns of testosterone secretion between Westernized and non-Western men, considerable variability exists in men's testosterone levels and prostate cancer rates within Westernized populations. Here, I use evolutionary life history theory as a framework to examine prostate cancer risk. Life history theory posits trade-offs between investment in early reproduction and long-term survival. One corollary of life history theory is the ‘challenge hypothesis’, which predicts that males augment testosterone levels in response to intrasexual competition occurring within reproductive contexts. Understanding men's evolved steroid physiology may contribute toward understanding susceptibility to prostate cancer. Among well-nourished populations of Westerners, men's testosterone levels already represent an outlier of cross-cultural variation. I hypothesize that Westernized men in aggressive social environments, characterized by intense male–male competition, will further augment testosterone production aggravating prostate cancer risk.


Introduction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

Prostate cancer represents a serious and rapidly growing health concern, and is now the second most common cancer among men. Western-industrialized societies have significantly higher rates of prostate cancer incidence, prevalence, and mortality than all others (Hsing et al. 2000; Kamangar et al. 2006). Global cancer statistics indicate that developed regions have a sixfold higher rate of prostate cancer incidence than developing regions (Kamangar et al. 2006). And for American men, prostate cancer is the second most common cancer and second leading cause of cancer death (Centers for Disease Control and Prevention and National Cancer Institute 2012), with an estimated 241,740 new cases and 28,170 deaths in 2012 (Howlader et al. 2012). Prostate cancer rates vary markedly both within and between populations (Fig. 1) (Hsing et al. 2000; Kamangar et al. 2006; Alvarado 2010). Understanding the underlying causes of this variation is important for cancer prevention and risk stratification.

image

Figure 1. Age-standardized incident rates of prostate cancer. Data collected from Cancer Incidence in Five Continents, Vol. IX (Curado et al. 2007).

Download figure to PowerPoint

Numerous risk factors for prostate cancer have been identified, including ancestry, diet, socioeconomic status (SES), and endogenous steroid concentrations (Grönberg 2003; Hsing and Chokkalingam 2006; Sanderson et al. 2006). However, these factors are frequently inconsistent, showing positive associations with prostate cancer in some studies and no, or even negative, associations in others (Meikle and Stanish 1982; Kolonel 2001; Sanderson et al. 2006; Roddam et al. 2008; Alvarado 2010). In this review, I focus on the effects of the steroid hormone testosterone, because substantial evidence suggests that cumulative, lifetime exposure to testosterone is a strong predictor of prostate cancer risk (Alvarado 2010). I argue that recognized risk factors for prostate cancer are likely proxies for chronically elevated testosterone exposure, and argue further that contradictory findings in the literature can be resolved by considering the specific ecological conditions that increase testosterone production. Evolutionary biologists have developed strong theories about how selective forces drive variation in testosterone levels between individuals, populations, and species (e.g., Wingfield et al. 1990; Ketterson and Nolan 1992; Bribiescas 1996, 2001a). Applying an evolutionary perspective to the problem of prostate cancer opens new avenues for understanding its etiology. It is my contention that commonly recognized risk factors, such as ancestry, dietary composition, and SES, will lead to higher prostate cancer rates only to the extent that they covary with socioecological factors influencing men's testosterone levels.

While other contributions to this Special Issue on Evolution and Cancer pertain to somatic evolution of neoplasia, this review addresses environmental and social conditions that affect cancer risk.

Part 1: Elevated testosterone as a risk factor for prostate cancer

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

Androgens play a vital role in men's reproductive biology, initiating the process of sexual differentiation, supporting spermatogenesis, precipitating the development of secondary sexual characteristics, and maintaining sexual function in adulthood (Bribiescas 2001a; Krause 2006). Testosterone and its metabolites also influence the growth and functioning of the prostate gland, which secretes important components of seminal plasma (O'Malley 1971; Platz and Giovannucci 2004). Testosterone is transported to the prostate in circulation, where it is metabolized by the enzyme 5α-reductase into a more potent androgenic form dihydrotestosterone (DHT) (Matsumoto 2001). DHT binds to androgen receptors in the prostate with high affinity, promoting cellular proliferation of prostatic epithelium (Hsing 2001). Considerable evidence suggests that increased exposure to testosterone is associated with an elevated risk of sex-specific morbidity and mortality (Hamilton and Mestler 1969; Holden 1987), including prostate carcinoma (Henderson et al. 1982; Hsing et al. 2008; Alvarado 2010).

Animal models, clinical research, and in vitro studies have an established history of demonstrating the proliferative effects of testosterone on prostate cells and tumors (reviewed in Grönberg, 2003; Henderson et al. 1982; Hsing et al. 2008; Smith et al. 1994), though findings from epidemiological studies have been less consistent (Roddam et al. 2008; but see Shaneyfelt et al. 2000). Experimental studies in men, dogs, and rats showed that testosterone administration induced development of prostate cancer, while tumor size shrinks from androgen ablation treatment (Huggins and Hodges 1941; Pollard et al. 1982; Miyamoto et al. 2004). Similarly, a 7-year clinical trial of elderly men using finasteride, a drug that inhibits metabolization of testosterone to DHT, resulted in a 25% decrease in prostate cancer prevalence (Thompson et al. 2003). Furthermore, eunuchs who were castrated as young men do not develop prostate cancer, nor do men with hereditary deficiency of 5α-reductase (reviewed in Miyamoto et al. 2004). This is in contrast to habitual anabolic steroid users who show enlarged volume of central prostate tissue compared with age-matched, eugonadal controls (Jin et al. 1996).

On a larger cross-cultural scale, higher testosterone levels are found in Westernized men when compared with men from developing or traditional populations (Ahluwalia et al. 1981; Ellison et al. 1989, 2002; Christiansen 1991; Bentley et al. 1993; Bribiescas 1996, 2001a; Ellison and Panter-Brick 1996; Santner et al. 1998; Campbell et al. 2003; Kehinde et al. 2006), and the highest rates of prostate cancer are also found within developed regions of the world (Hsing et al. 2000; Kamangar et al. 2006; Curado et al. 2007). Population disparities in testosterone levels are most pronounced among young men (Fig. 2). Westernized men have higher testosterone levels but show a precipitous age decline in testosterone levels following early adulthood (Gray et al. 1991; Ellis and Nyborg 1992; Jankowska et al. 2000; Uchida et al. 2006), whereas men from preindustrial societies have lower testosterone levels followed by a less pronounced decline throughout the lifespan, and no appreciable difference exists between these groups in later life (Ellison et al. 1989, 2002; Bribiescas 2001a; Kehinde et al. 2006). Thus, prominent testosterone disparities in early life are not evident at later ages.

image

Figure 2. Mean testosterone levels across the lifespan of men from the USA and three preindustrial societies (Ellison et al. 2002).

Download figure to PowerPoint

Despite accumulating evidence, the association between testosterone exposure and prostate cancer has proven controversial, largely because epidemiological studies have failed to find elevated testosterone levels in men with prostate cancer compared with healthy, age-matched controls (e.g., Andersson et al. 1993; Carter et al. 1995; de Jong et al. 1991; Hsing and Comstock 1993; Kubricht et al. 1999; Roddam et al. 2008; Sofikerim et al. 2007; but see Gann et al. 1996; Parsons et al. 2005; Shaneyfelt et al. 2000; Wolk et al. 1997). However, prostate cancer is primarily a disease of old age (Grönberg 2003; Hsing and Chokkalingam 2006), a period when men's testosterone profiles are diminished (Ellis and Nyborg 1992; Ellison et al. 2002; Gapstur et al. 2002; Kehinde et al. 2006). A major limitation of case–control studies of late-middle aged and elderly men is the lack of information on cumulative testosterone exposure over the life course.

Because the highest and most variable testosterone levels are found in young men, relative differences in men's cumulative hormone exposure can be most clearly identified during early adulthood (Grönberg 2003; Alvarado 2010), and these measures do correlate with prostate cancer risk. For example, African-American men have the highest incident rate of prostate cancer (Curado et al. 2007) and the highest average testosterone levels of all Western ethnic groups (Ross et al. 1986; Ellis and Nyborg 1992; Winters et al. 2001; Kehinde et al. 2006), but the latter difference is not detectable among older men (Ellis and Nyborg 1992; Kubricht et al. 1999; Pettaway 1999). Prostate cancer disparity between African- and Caucasian-Americans is evident as early as age 45, again suggesting that hormone exposure in young adulthood affects the trajectory of cancer risk in later life (Ross et al. 1986). Many studies have reported higher testosterone levels in young men from groups with higher prostate cancer incidences (Ross et al. 1986; Ellis and Nyborg 1992; Winters et al. 2001; Jakobsson et al. 2006; Kehinde et al. 2006). Moreover, meta-analyses that included only study samples of young men have reported that population differences in testosterone levels were positively and significantly associated with prostate cancer disparities in older men (Alvarado 2010, 2011).

Since men living in Westernized industrial conditions exhibit testosterone levels at an extreme for the observed range of human variation (Bribiescas 2001a), the question then becomes which factors result in further augmentation of testosterone production and whether these factors are associated with the prevalence of androgen-sensitive disease. Evidence for constitutional and ecological influences on steroid hormone production and metabolism is examined, with the prediction that socioecological factors supporting elevated testosterone will be associated with an increased risk of prostate cancer. Although this review primarily concentrates on variation in circulating testosterone levels, it is important to acknowledge that variation in androgen receptor sensitivity, carrier protein levels, and testosterone metabolization to DHT are all involved in androgenic action within the prostate (Hsing et al. 2008).

Part 2: Life-history trade-offs affecting reproductive physiology

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

Life history theory provides a constructive theoretical framework for attaining greater insight in the evolutionary origins of a given trait. This becomes especially relevant if the trait under investigation is linked to a disease outcome that escalates with modernity, and may suggest an evolutionary mismatch in which a trait's adaptive function becomes maladaptive within an evolutionarily novel environment (Eaton et al. 2002). This section provides a brief overview of life history theory, while subsequent sections address how life history principles can inform our understanding of prostate carcinogenesis.

A primary determinant of evolutionary fitness is an organism's ability to capture energy from its environment and convert it into viable offspring, and a fundamental concept in life history theory is that energy allocated to one area is no longer available for investment in another. Because energy in the environment is finite, and because energy is not available once spent, selection favors strategic energy allocation across competing body systems in order maximize an organism's reproductive success. Differential energy allocations between growth, maintenance of soma, and reproduction define separate stages of the life course (Gadgil and Bossert 1970; Stearns 1989).

Mammals begin life dividing energy investment between growth and somatic maintenance (e.g., immune function), while reproduction is delayed. Once growth is nearly complete, the primary trade-off then shifts between reproduction and maintenance (Hill 1993; Kaplan et al. 2000). Investment in reproduction can be further divided into parental effort or mating effort. In mammals, females support the energetic cost of reproduction in the form of internal gestation and lactation (Clutton-Brock and Vincent 1991). Because females provide the greater minimum obligatory investment in offspring, females invest primarily in parental effort (Trivers 1972). Males, on the other hand, have more latitude in their reproductive decisions and are able to preferentially invest in either parental or mating effort (Ibid.), though direct male investment in progeny is quite rare among mammalian species (Clutton-Brock and Parker 1992). For males, spermatogenesis is energetically cheap, less than 1% of basal metabolic rate (Elia 1992), and male fecundity is relatively insensitive to energetic constraint (Bribiescas 2001a). In contrast, behavioral and secondary sexual characteristics are often costly for males in terms of energy expenditure, immunosuppression, or extrinsic mortality (Bribiescas 2001a; Muehlenbein and Bribiescas 2005; Ketterson and Nolan 1992; Redpath et al. 2006; Wilson and Daly 1985; Zahavi 1975). In vertebrates, testosterone has a critical role in modulating male life history and reproductive strategies (Bribescas, 2001; Ketterson and Nolan 1992; Wingfield et al. 1990) and will be discussed further in later sections.

Part 3: Biosocial influences on testosterone production

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

Because several measures of endogenous testosterone are reported in the literature, a concise summary is presented in the Appendix for readers unfamiliar with these measurements.

Nutritional status affects testosterone levels

Energy availability has a central role in calibrating men's testosterone levels (Bribiescas 2001a). And as nutritional status is especially variable between populations (Fig. 3), cross-cultural differences in energetic stress should have clear effects on interpopulation variation in testosterone levels (Ellison et al. 2002). In this section, between-population variation in men's testosterone levels is examined. Emphasis was placed on comparing Westernized populations with developing and small-scale societies, because shifts in dietary habits and activity patterns that accompany urbanization influence the expression of men's steroid physiology. Subsistence food production is often accompanied by chronic energy shortage, and men living under these conditions are generally incapable of meeting the energetic demands of physiological processes associated with elevated testosterone (Bribiescas 1996, 2001a; Ellison and Panter-Brick 1996; Ellison et al. 2002).

image

Figure 3. Daily per capita supply of calories, which represents the available calorie supply averaged across the population (United Nations Development Programme 2000).

Download figure to PowerPoint

Bribiescas (1996, 2001a) proposed a functional explanation for observed variation in men's testosterone profiles. Males face a trade-off between somatic maintenance and reproduction that is modulated by testosterone's management of sexually dimorphic muscle mass. Although enhanced muscular development can improve competitiveness for mates, through male–male competition or female choice, it also raises metabolic rate and is energetically costly. According to Bribiescas, favorable energy availability promotes elevated testosterone to support muscular hypertrophy, while energetic stress results in down-regulated testosterone production and a diminished, thriftier phenotype. Whether diminution and augmentation of men's musculature is mediated through this specific pathway remains an interesting but tentative hypothesis, because some studies failed to substantiate that natural variation in men's testosterone levels exerts somatic consequences on muscle mass (Häkkinen and Pakarinen 1993; Ellison and Panter-Brick 1996; Campbell et al. 2003; Gettler et al. 2010) while other studies report only weak or indirect relationships (Campbell et al. 2007; Ellison and Panter-Brick 1996; Gettler et al. 2010; Lukas et al., 2004).

It is well established, however, that men from populations under chronic energy shortage exhibit lower total and free testosterone levels in saliva and serum (Christiansen 1991; Bentley et al. 1993; Bribiescas 1996, 2001a; Ellison and Panter-Brick 1996; Campbell et al. 2003). Among Ariaal pastoralists of Northern Kenya, an examination of men's salivary testosterone levels and body composition in a sample of nomadic and settled Ariaal found that nomadic males had lower body fat percentage than settled males along with lower evening salivary testosterone values (Campbell et al. 2003). Nomadic men also showed a more pronounced age decline in both body fat and morning testosterone, which the authors attributed to energetic stress constraining testosterone levels of older men. Additionally, body fat was a positive predictor of morning testosterone levels, though testosterone levels were not associated with muscle mass. A subsequent study of the same population found that lean body mass was predicted by an interaction between evening salivary testosterone and androgen receptor sensitivity that was assessed using length of CAG repeats (Campbell et al. 2007). Conversely, an experimental examination reported dose-dependent effects of testosterone administration on young men's anabolic response without interaction from CAG repeat length (Woodhouse et al. 2003), and it remains uncertain to what extent the distribution of CAG repeats alters transcriptional activity of the androgen receptor gene.

Body fat percentage also positively predicted salivary testosterone levels in a sample of young Filipino men (Gettler et al. 2010). Once again, testosterone levels were not associated with muscle mass or strength measures, but there was an interaction between testosterone levels and sports participation in relation to lean body mass as well as grip strength. And in a study of men's reproductive hormones across urbanization gradient and economic strata within the developing population of South Africa, serum testosterone levels varied according to modernity and socioeconomic status (Gray et al. 2006a). Social groups within this study consisted of tribal men from rural villages, commercial farm workers, men residing in informal slum settlements (‘squatter camps’), urban inhabitants with access to public water and electricity, and urban professionals living in upper-class suburbs—with urban professionals representing the most Westernized lifestyle. Urban living and affluence were associated with both higher serum testosterone and body mass index, which is suggestive that increased testosterone production was supported by the superior energetic status of well-nourished urban professionals. Interestingly, the effect of nutritional constraint on testosterone secretion has been reported in comparisons of wild and captive chimpanzee males. Relative to their wild counterparts, captive chimpanzees are more sedentary with greater food availability, and captive males demonstrate higher urinary testosterone than wild males (Muller and Wrangham 2005). The comparison of captive and wild populations can provide a useful analog for domesticated animals. For example, household pets have less energetic constraint than would be expected in the wild. It seems reasonable to think that this ecological transition would have implications in regards to sex steroids levels and susceptibility to hormone-sensitive cancer. To my knowledge, no studies have compared steroid hormone levels in household pets and feral conspecifics. However, it is worth considering that aside from humans and synthetically induced cancer in laboratory rats, the only mammal that regularly develops prostate cancer is domestic non-neutered dogs, and sporadic reports of prostate cancer in cats have surfaced (Leroy and Northrup 2009).

In stark contrast to the marginal nutritional status of traditional or developing populations, Westernized men have an energy budget capable of supporting distinctly elevated levels of testosterone (Bribiescas 2001a). Indeed, it has been suggested that the near absence of severe energetic stress in Western populations permits male steroid physiology to operate at near maximal capacity (Bribiescas 2001b). Another potential constraint on hormone levels of non-Western men is greater exposure to pathogenic agents and infectious disease. Although it is overly simplistic to label testosterone as immunosuppressive, there is evidence that androgenic hormones can suppress some aspects of immune function, and conversely, immune challenges can suppress testosterone levels (reviewed in Muehlenbein and Bribiescas 2005; Muehlenbein 2008). If this is the case, then elevated testosterone would impose a disproportionate cost for men living in pathogen-rich ecologies of indigenous and developing habitats. Even in healthy US men, a mild immune challenge such as influenza vaccination can induce a subsequent decrease in salivary testosterone levels during the time of peak antibody production (Simmons and Roney 2009).

Under circumstances when Western men experience acute or chronic malnutrition, the subsequent physiological response is to lower testosterone levels (Klibanski et al. 1981; Lado-Abeal et al. 1999; Tomova and Kumanov 1999). Low levels of serum total testosterone and other signs of suppressed testicular function have been reported in young European men diagnosed with anorexia nervosa (Tomova and Kumanov 1999). Among collegiate wrestlers, lower serum testosterone levels were associated with low body fat as well as fat loss, and wrestlers showed decreased testosterone levels during the competitive season when energetic stress is most pronounced (Strauss et al. 1985). And obese men who have considerable energetic surplus in the form of abundant fat reserve still show lower serum testosterone after fasting (Klibanski et al. 1981). Moreover, a recent study found that a single missed meal in male college students can alter the male reproductive axis by decreasing luteinizing hormone and salivary testosterone levels (Trumble et al. 2010). But it is not entirely clear to what extent men's androgen production is constrained by transitory energy deficits; studies conducted within non-Westernized societies have found that seasonal workload and food shortage is not associated with lower salivary testosterone levels (Bentley et al. 1993; Ellison and Panter-Brick 1996). Similarly, a study of wild chimpanzees reported that males do not have lower urinary testosterone during the dry season when fruit is less available and energetic stress intensified (Muller and Wrangham 2005).

Although men's testosterone levels are affected by their nutritional status, the pattern diverges between Westerners and non-Westerners. For men living at subsistence level, higher adiposity can be indicative of superior energetic condition capable of supporting elevated testosterone (Ellison and Panter-Brick 1996; Campbell et al. 2003; Gettler et al. 2010). In contrast, high calorie consumption for Westerners, who are already well-nourished, is associated with fat accumulation and lower testosterone levels because of peripheral aromatization of androgens within adipose tissues (Kley et al. 1980, 1981; Pritchard et al. 1998). Large- and small-scale nutritional studies have found that measures of adiposity are negatively correlated with men's serum levels of total, free, and bioavailable testosterone in Westernized populations (Giagulli et al. 1994; Gapstur et al. 2002; Jensen et al. 2004; Tsai et al. 2006). And while greater energy consumption in Western men is correlated with higher adiposity and lower testosterone levels (Bishop et al. 1988; Pritchard et al. 1998), there is little empirical support showing a direct, causal relationship between diet composition and alterations in men's androgen production (Allen and Key 2000). An analysis of serum sex steroids levels in a sample of American monozygotic twins found that neither total nor free testosterone was associated with macronutrient consumption (Bishop et al. 1988; also see Field et al. 1994). Some androgenic metabolites were negatively correlated with calorie, fat, and protein consumption, while carbohydrate intake showed a positive correlation. However, the strongest determinants of men's testosterone was adiposity and body weight, both inversely related to testosterone levels, suggesting that dietary influences on testosterone levels were acting through the effects of body composition.

Nutritional analyses of Western men have not supported a direct effect of diet on testosterone levels after accounting for anthropometric differences (Key et al. 1990; Field et al. 1994; Allen and Key 2000). Allen and Key (2000) conducted a comprehensive survey of the literature on men's hormones, body composition, and diet among population samples that were drawn almost entirely from Westernized groups. They found that energy intake along with proportional intake of fat, protein, carbohydrate, and fiber as well as habitual diet (meat-eaters, vegetarians, and vegans) had a diminutive influence on hormone levels relative to the effects of body mass index and age. Some researchers have suggested that dietary habits do not adequately explain ethnic variation in testosterone levels of American men, because consumption of major nutrients does not differ significantly between American ethnic groups within the same social class while serum total and free testosterone levels do (Ross et al. 1986). Taken altogether, dietary composition among well-nourished Westerners does not appear to be a probable candidate for explaining variation in men's testosterone levels. Furthermore, variation in dietary regimens does not appear to contribute toward recognized differences in testosterone levels among Western ethnic groups. While dietary composition may not be associated with testosterone levels among Westernized men, this does not necessarily preclude other carcinogenic effects, outside of androgenic stimulation, of a Western-style diet on the prostate gland.

In summation, this section focused primarily on explaining cross-cultural variation in the testosterone levels of Westernized and non-Western men. Westernized men have greater energy availability and can support testosterone levels at the highest range of human variability, while men living at subsistence level are subjected to a higher degree of energetic stress and exhibit significantly lower testosterone levels. Variation in the dietary composition of Westerners does not seem to influence men's testosterone levels, although acute and chronic energetic stress does. Understanding the reproductive ecology underlying population differences in men's testosterone levels will go a long way in understanding prostate cancer disparities. This last point is particularly relevant because of evidence that population disparities in testosterone levels and prostate cancer are causally related (Alvarado 2010).

Until this point, I have focused on explaining between-population variation. The following sections will consider factors that affect testosterone levels and prostate cancer risk within populations. The first potential factor is ancestry.

Ancestry is not associated with prostate cancer risk

Although ancestry is often thought to be a robust predictor of men's testosterone levels, an overview of this supposition reveals that supporting evidence is lacking. Ethnic variation in testosterone levels and prostate cancer rates has produced causal explanations for these disparities based on ancestry. Earlier it was mentioned that African-American men have the highest testosterone levels and greatest risk of prostate cancer (Ross et al. 1986; Ellis and Nyborg 1992; Winters et al. 2001), which have been attributed to a constitutional trait associated with African ancestry (Ellis and Nyborg 1992; Pettaway 1999). Contrary to this hypothesis, African-Americans have an extraordinarily high rate of prostate cancer when compared with African regions for which data are available, including West Africa (Curado et al. 2007; Kovi and Heshmat 1972; but see Odedina et al. 2006). Some researchers have taken the low incidence of prostate cancer found among African nationals as indirectly suggestive of lower testosterone levels in African populations (Ross et al. 1986), and there is empirical evidence that urban and indigenous groups of African men possess lower levels of serum total and free testosterone and salivary testosterone than either white or black American men (Ahluwalia et al. 1981; Ellison et al. 1989; Christiansen 1991; Bribiescas 2001a,b). Taken together, ancestry does not sufficiently explain elevated testosterone or prostate cancer risk in the ethnic group possessing the highest values. Furthermore, observed differences in the testosterone levels of young black and young white American men no longer exist after controlling for anthropometry and lifestyle factors (Rohrmann et al. 2007).

In contrast to higher testosterone levels of African-American men, lower levels of serum total, free, and bioavailable testosterone and lower salivary testosterone have been reported in men of Arabic and Asian descent: Chinese, Japanese, Kuwaiti, Omani, and Pakistani men (de Jong et al. 1991; Santner et al. 1998; Heald et al. 2003; Jakobsson et al. 2006; Kehinde et al. 2006), which again would appear to suggest that the expression of men's steroid physiology is a dispositional trait associated with ancestry (Ross et al. 1992; Jakobsson et al. 2006; Kehinde et al. 2006), but this position has also received little empirical support. One study reported that Chinese-American men have serum total testosterone levels that are significantly higher than Chinese nationals but not significantly different from white Americans (Santner et al. 1998). Similarly, Japanese-Americans exhibit much higher rates of prostate cancer than Japanese nationals (Severson et al. 1989; Shibata et al. 1997; Curado et al. 2007).

It is indisputable, however, that Arab and Asian men demonstrate remarkably low rates of prostate cancer (Yu et al. 1991; Kamangar et al. 2006; Curado et al. 2007), and cancer researchers have continued to search for risk factors associated with ancestry. Ross et al. (1992) reported that circulating levels of 5α-reduced metabolites were lower in Japanese men relative to other ethnic groups that exhibit higher risk of prostate cancer, which is intriguing since proliferation of prostatic epithelial cells is directed through testosterone metabolization to DHT by the enzyme 5α-reductase. Ross and colleagues proposed that a dispositional trait of Asian ancestry is responsible for a diminution of 5α-reductase activity, and that the lower prevalence of prostate cancer among Japanese men results from decreased exposure of prostate tissue to DHT. However, the indices of 5α-reductase activity used by Ross et al. (3α-androstanediol glucuronide and 3α-androsterone glucuronide) are strongly affected by adrenal steroid levels (Giagulli et al. 1989). Employing a more refined methodology that isolated gonadal sources of 5α-reduced metabolites, Santner et al. (1998) reported no notable differences in 5α-reductase activity between Caucasian-American and Chinese population samples; a similar result has since been replicated using a comparison of testosterone metabolism in white Australian and Chinese men (Jin et al. 2000). Accordingly, it seems that androgenic stimulation from higher testosterone levels, rather than 5α-reductase activity, is responsible for documented variation in prostate cancer rates between men of European and Asian descent (Kehinde et al. 2006). Some researchers have proposed that susceptibility to prostate cancer is determined by heightened sensitivity toward androgens resulting from the number of CAG and GGC microsatellites in exon 1 of the androgen receptor gene (Irvine et al. 1995; Giovannucci et al. 1997; Ross et al. 1998) and that the distribution of nucleotide polymorphisms is linked to ancestry (Kubricht et al. 1999; Pettaway 1999; Mohler 2007). This hypothesis has garnered limited support, because there are mixed reports of whether these genetic variants affect cancer outcomes (Grönberg 2003), and ethnic disparities in prostate cancer are not always consistent with ethnic variation in androgen receptor genotypes (Jin et al. 2000; but see Sartor et al. 1999). As such, ancestry does not effectively account for variation in testosterone levels and prostate cancer risk in ethnic groups possessing the lowest values, either.

In summation, ancestry does not adequately explain variation among ethnic groups with higher or lower testosterone levels, nor does it appear to explain variation among ethnic groups with high or low prostate cancer rates. This calls into question the efficacy of a disease model that is unable to predict either deleterious or protective effects.

Socioeconomic status is often negatively associated with prostate cancer risk

Socioecological correlates of economic strata can influence male steroid production, as was apparent in the case of South African men discussed earlier. Fiscal resources are correlated with many aspects of health status (e.g., Smith et al. 1996a,b; Singh et al. 2003). Although national gross domestic product per capita is generally regarded as a positive predictor of health and longevity, this relationship more accurately captures relative differences between developing and developed countries (World Health Organization, 2002). Comparisons limited to affluent populations find that health outcomes are more closely tied to distribution of wealth within a nation's populace. Living in poverty within affluent countries is associated with a lower life expectancy, a greater prevalence of noncommunicable diseases, more prevalent drug and alcohol use, lack of access to healthcare, and higher rates of victimization from violent crime (Smith et al. 1996a,b; Ringel 1997; World Health Organization, 2002). Income disparities within industrialized nations often correlate with prostate cancer risk. Multiple studies have found increased morbidity and mortality from prostate cancer in men of lower social and economic status (Singh et al. 2003; Hall et al. 2005; Du et al. 2006 Sanderson et al. 2006; Rapiti et al. 2009). However, these findings were not replicated in a Norwegian population (Lund-Nilsen et al. 2000), which is of considerable interest and will be revisited.

Part 4: The challenge hypothesis and prostate cancer risk

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

In this section, I draw on evolutionary theory to propose a new perspective on lifetime variation in testosterone exposure and consequent rates of prostate cancer. I build on research addressing between-population variation in testosterone levels, by further addressing social contexts that can lead to higher testosterone levels within Westernized populations—given that Westernized men can afford the energetic cost of elevated testosterone. More specifically, I propose that aggressive social environments place a premium on male–male competition and mating effort, formally termed the challenge hypothesis, which leads to chronically elevated testosterone and increased prostate cancer risk.

Wingfield et al. (1990) formulated the challenge hypothesis to explain variability in androgen production among seasonally breeding birds. At the beginning of the breeding season, males' testosterone levels raise from a nonbreeding baseline to a breeding baseline. Males then begin to establish territories, compete for mates, and intensify mate-guarding behavior as the breeding season progresses, exacerbating agonistic interactions with other males. During the period of mating competition, males' testosterone levels raise to a maximum baseline exceeding what is physiological necessary for male fecundity or secondary sexual characteristics. In monogamously mating bird species, mating effort decreases after a mateship is established as males move into a parenting role, and testosterone levels return to the breeding baseline from the physiological maximum. In contrast, polygynous male birds do not invest in parenting, compete for access to multiple females, and circulating testosterone does not decline from its physiological maximum during this time. Wingfield and colleagues presented convincing evidence that males' maximal rise in testosterone was elicited solely by aggressive challenges from male conspecifics in contexts directly relevant to reproduction. Thus, the effect of testosterone on aggressive competition complements its other effects on reproductive function and behavior. Elevated circulating testosterone is not without costs, however. In red grouse, for example, males treated with testosterone achieved higher mating success and were more likely to have multiple sexual partners than control males. And although treated males produced, on average, 2.5 more offspring than controls, they also suffered increased mortality from higher rates of predation (Redpath et al. 2006).

The same manner of challenges influencing testosterone secretion in birds can induce an analogous response in primate species. Direct male–male competition and aggression are associated with increased circulating testosterone. Furthermore, among group-living primates, males' testosterone levels are also responsive to the defense and maintenance of social status (Muller and Wrangham 2004; Archer 2006). The challenge hypothesis, adapted for primate species, has found support in prosimians (Cavigelli and Pereira 2000), monkeys (Beehner et al. 2006), apes (Muehlenbein et al. 2004; Muller and Wrangham 2004), and humans (Archer 2006). In chimpanzees, males that obtain sexual access to a noncontested mate do not show elevated testosterone levels, whereas males that must aggressively compete for access to females show a marked increase in testosterone. In a similar vein, an extensive meta-analysis found consistent support, across a wide range of studies, for the responsiveness of men's testosterone levels toward male–male competition (Archer 2006), and men with either more exposure to or involvement in violent behavior demonstrate higher testosterone levels (Dabbs and Morris 1990; Archer 1991, 2006; Dabbs et al. 1991; Banks and Dabbs 1996; Mazur 2006).

It seems reasonable that male hormonal response to challenges will have important health implications for men living in aggressive social environments, particularly those with the energetic resources to support high testosterone levels. For Westernized men from areas with a high intensity of male–male aggression and competition, the chronic nature of challenges may support chronically elevated levels of testosterone. Relative to other Americans, for example, African-Americans are subjected to a higher intensity of acute poverty, which produces downstream societal effects that amplify male–male competition, such that young African-American men experience more severe, repeated episodes of violence, as well as increased rates of homicide (Sampson and Wilson 1995; Geronimus et al. 1996; Ringel 1997). As would be expected in a social ecology with intensive male–male aggression, African-American men have repeatedly demonstrated serum total and free testosterone levels that are significantly higher than all other ethnic groups (Ross et al. 1986; Ellis and Nyborg 1992; Ettinger et al. 1997; Winters et al. 2001) and also have the highest incident rate of prostate cancer (Ghafoor et al. 2002; Merrill and Morris 2002; Curado et al. 2007; Altekruse et al. 2010). Irrespective of ethnicity, however, American men of low socioeconomic status experience increased rates of violent crimes (Ringel 1997), have higher serum testosterone levels (Dabbs and Morris 1990; Dabbs 1992), and suffer a higher rate of prostate cancer incidence and mortality (Singh et al. 2003; Hall et al. 2005; Du et al. 2006; Sanderson et al. 2006).

Mazur (1995, 2006) argued that heightened dominance contests among economically disenfranchised men underlie recognized differences in testosterone levels between American ethnic groups. According to Mazur, impoverished conditions within American inner-city communities place a premium on dominance challenges between males, particularly young men. He argued that this association is evidenced by an overrepresentation of young, urban black men in the homicide statistics as both perpetrators and victims. Mazur analyzed ethnic variation in testosterone levels with respect to years of completed education using a large sample of US veterans, given that educated African-American men were less likely to come from impoverished urban areas. He found significantly different serum testosterone levels between young black and young white American men who had never completed high school, but this difference did not persist in college-educated men (Fig. 4). These data are suggestive that a social environment characterized by a high intensity of dominance contests can maintain elevated testosterone, as was evident among inner-city, African-American men.

image

Figure 4. Testosterone levels according to ethnicity and education in a sample of male American veterans; median age of the sample was 37 years (redrawn from Mazur 1995).

Download figure to PowerPoint

It has long been observed that dominance contests, sometimes violent, occur more frequently among young men, leading researchers to term this phenomenon the ‘young male syndrome’ in which single young men are prone to risk taking and confrontational disputes to compete for potential mates (Wilson and Daly 1985). Aggression from male–male contests can often be explained in terms of investment in mating effort (e.g., Wilson and Daly 1985; Wingfield et al. 1990; Muller and Wrangham 2004; Archer 2006; Beehner et al. 2006). As reviewed in this section, the challenge hypothesis provides a practical framework to contextualize male–male competition and investment toward mating effort; the other integral component of this hypothesis addresses when males shift from mating effort to an investing parent.

Human males are especially unique in their extent of provisioning mates and offspring, and there is considerable evidence that this divergence from the reproductive strategies of other primates affected the course of human evolution (Lancaster and Lancaster 1983; Kaplan et al. 2000). As in any paternally investing species, human males face a particularly salient trade-off in reproduction between mating effort and parenting effort (Geary 2005). Numerous studies have examined hormonal changes occurring when single men transition to investing fathers (e.g., Gray et al. 2002; Muller et al. 2009; Gettler et al. 2011). Suppressed testosterone levels following the introduction of paternal care have been interpreted as a physiological shift away from mate-seeking behavior and toward investment in a current partner with shared offspring (Ibid.). Cross-sectional and longitudinal data have consistently reported that involved fathers demonstrate lower testosterone levels than unpaired males, and this finding is cross-culturally robust with the same general trend found in American, Canadian, Chinese, Filipino, Hadza, Jamaican, and Swahili men (Gettler et al. 2011; Fleming et al. 2002; Gray 2003; Gray et al. 2002, 2006b; Muller et al. 2009). Gettler et al. (2011) collected nearly 5 years of data on a nationally representative sample of Filipino men. They found that men with elevated levels of morning salivary testosterone were more likely to find mates and begin reproducing by the end of the observation period, which was then followed by an abrupt decline in testosterone levels after becoming fathers. These findings were particularly compelling, because longitudinal data showed that men's mating success was predicted by higher testosterone levels, while the demands of parenting effort down-regulated men's testosterone production.

Of course, considerable variation exists in the amount men invest in offspring, and men who have less involvement with their children deviate from the pattern described above. Muller et al. (2009) compared male parenting in two neighboring African populations. The Hadza and Datoga of Tanzania live in close proximity but have different modes of subsistence, leading to dissimilar patterns of pair-bonding and paternal involvement. Hadza live as traditional hunter-gatherers and are principally monogamous in which fathers are heavily involved with parental care. Datoga, on the other hand, subsist through pastoral farming and are patrilineal and polygynous, and males strive to acquire wives throughout their lifetime with little direct involvement in parenting. Thus, Hadza men shift investment from mating to parenting effort once a reproductive union is established, while Datoga men continue investing in mating effort after becoming fathers. These contrasting parenting strategies are manifested in the steroid physiology of Hadza and Datoga fathers. Hadza men show a pattern of higher salivary testosterone in single men and lower levels in pair-bonded fathers, while Datoga men maintained higher salivary testosterone after becoming fathers and throughout their reproductive years.

Some researchers have contemplated whether hormonal changes accompanying fatherhood affects health outcomes, including prostate cancer (Gettler et al. 2011). This would be especially relevant for Westernized men who experience a high degree of testosterone exposure. Since male parental involvement, rather than fatherhood in itself, appears to be the impetus for reduction of circulating testosterone (e.g., Gray 2003; Muller et al. 2009), it also becomes important to consider men's parenting strategies along with environmental circumstances that influence male investment patterns.

An obvious constraint to parenting effort is mortality risk, and there is evidence that local death rates affect the expression of reproductive strategies in which risky environments lead to preferential investment in mating effort (reviewed in Chisholm, 1993). This may be the case for marginalized populations where men's ability to invest in children is compromised, such that parenting effort would be devalued and mating effort prioritized. In African-American communities, poverty is associated with significantly higher rates of intrinsic and extrinsic mortality (Geronimus 1996; Geronimus et al. 1999), and men from these communities are disenfranchised in additional ways that compromise paternal involvement. African-American men have disproportionate rates of incarceration, poverty, unemployment, and underemployment (Western 2002). From a life-history perspective, it is reasonable to expect males living in adverse and unpredictable conditions to invest preferentially in mating effort. Consistent with this logic, African-American communities display a suite of behavioral and physiological characteristics at the population level that are indicative of males prioritizing mating effort; men demonstrate a high degree of paternal disinvestment, male–male competition, and elevated testosterone levels. Put another way, widespread and severe poverty found among African-American communities is associated with higher rates of homicide and violent crime (Sampson and Wilson 1995; Geronimus et al. 1996; Ringel 1997), single mother households (Geronimus 1996; Mather 2010), elevated total and free serum testosterone (Ross et al. 1986; Ellis and Nyborg 1992; Mazur 1995, 2006), and might culminate into exceedingly high rates of prostate cancer (Du et al. 2006; Sanderson et al. 2006). Consequently, in addition to the immediate health concerns that impoverished living conditions pose, later deleterious effects may include persistently high testosterone and increased prostate cancer risk.

In summation, the literature reviewed in this section points to a direct relationship between male mating effort, aggressive challenges, and increased androgen production, a relationship that has been well documented across avian and primate taxa. Among Westernized men who have energetic resources to support the metabolic costs associated with elevated testosterone, there is evidence that being exposed to a higher frequency of aggressive challenges can result in chronically elevated testosterone levels. If living in an aggressive social environment contributes to prostate cancer disparities, this has important implications for prevention and risk stratification.

Discussion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

Modern Westernized environments represent a clear deviation from the environment in which male reproductive physiology evolved. Largely removed from energetic constraint and pathogen burden, Westernized men are capable of supporting distinctly elevated testosterone at the upper limit of human variability and amplifying the incidence of hormone-sensitive cancer. Variation in nutritional status can largely account for observed disparities in men's testosterone levels and prostate cancer between Westernized and non-Western populations, but not within Westernized populations—the populations at highest risk of prostate cancer. By incorporating a challenge hypothesis framework, another source of lifetime variation in testosterone exposure was proposed: Aggressive social environments affect prostate cancer incidence through the responsiveness of male androgen physiology to challenges, specifically among Westerners who are able to support the energetic costs of high testosterone levels. I reviewed literature which showed that ancestry, a widely recognized risk factor for prostate cancer, is in and of itself biologically unimportant when accounting for lifestyle factors. For instance, population disparities in testosterone levels of black-and white-American men become attenuated and nonsignificant when comparing among college-educated men from similar backgrounds (Mazur 1995, 2006). And in a nationally representative sample, there was no significant difference in testosterone levels of black-and white-American men after accounting for differences in anthropometry (age and body fat percentage) and lifestyle factors (drug use and physical activity) (Rohrmann et al. 2007). To reiterate, there is surprisingly little evidence to suggest that testosterone levels are a direct consequence of ancestry. And as discussed earlier, men of lower SES, regardless of ethnicity, demonstrate higher rates of male–male violence, higher testosterone levels, and higher prostate cancer. Using ancestry as a putative biomarker of prostate cancer risk is effective only to the extent which it tracks environmental circumstances and living conditions that influence cancer risk.

Additionally, I argued that poverty and compromised male investment lead to prioritized mating effort and increased male–male competition, culminating into chronically elevated testosterone and higher rates of prostate cancer. This general trend would be expected only if inequity in wealth distribution translated into more agonistic interactions between males at the population level. In other words, if the relationship between poverty and aggressive social environments is moderated, then there would be little expectation for lower SES to contribute to prostate cancer risk. Norwegian men, for example, deviate from the normally observed correlation between low SES and increased prostate cancer risk. This is particularly interesting because of the sizeable welfare program that is characteristic of Nordic social policy (Sachs 2006), which is associated with some of the lowest crime rates, violent or otherwise (Barclay et al. 2001). As such, Norway invests heavily in poverty reduction, boasts the lowest homicide rate within the developed world, and does not exhibit a concentration of prostate cancer among men of lower SES. Taken together, it would appear that comprehensive social programs might decouple socioeconomic differentials from male–male violence and prostate cancer risk, and may provide a surprising example of how improved social policies and poverty alleviation strategies are fundamental to the interest of public health.

And finally, the challenge hypothesis framework developed in this review may have occupational health implications, considering that men's testosterone levels vary according to occupational status (Dabbs 1992), and that some professions carry a disproportionate risk of prostate cancer (Demers et al. 1994; Zeegers et al. 2004). Dabbs (1992) and colleagues (1998) found that blue-collar workers have higher salivary and serum testosterone than white-collar workers. However, distinct social contexts within a profession can also give rise to differences in testosterone levels. Although lawyers as a group are white-collar workers, trial lawyers have significantly higher salivary testosterone than nontrial lawyers, which has been attributed to the polemical nature of face-to-face litigation (Dabbs et al. 1998). If this pattern of elevated testosterone from agonistic interactions persists across occupations, it seems reasonable to expect that men in professions with a higher intensity of competitive interaction would exhibit a greater incidence of prostate cancer. Findings from an extensive cohort study of 58,279 Western European men (ages 55–69 years) from 20 separate occupations are consistent with this reasoning (Zeegers et al. 2004). After accounting for individual characteristics and lifestyle factors (age, diet, drug and alcohol use, education, family disease history, and physical activity), it was police officers who showed the highest relative risk for prostate cancer. Indeed, prostate cancer risk increased 67% for each 10 years of occupational duty as a policeman. The framework proposed here can explain these seemingly peculiar associations between career choice and prostate cancer risk.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

The author thanks Melissa Emery Thompson, Jane Lancaster, and Martin Muller for many insightful discussions that led to the preparation of this manuscript, as well as for their comments on an earlier draft. The author is also indebted to two anonymous reviewers for their constructive critique that greatly improved the quality of this manuscript. And finally, the author is appreciative for the invitation to contribute to this Special Issue on Evolution and Cancer, and is grateful to Guest Editor Athena Aktipis for her input on an earlier draft. This research was supported by graduate research fellowships from the National Science Foundation 2008-2011, the Robert Wood Johnson Foundation Center for Health Policy 2011-2013, and the Program for Interdisciplinary Biological and Biomedical Sciences at University of New Mexico 2011-2013.

Literature cited

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures
  • Ahluwalia, B., M. A. Jackson, G. W. Jones, A. O. Williams, M. S. Rao, and S. Rajguru 1981. Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations. Cancer 48:22672273.
  • Allen, N. E., and T. J. Key 2000. The effects of diet on circulating sex hormone levels in men. Nutrition Research Reviews 13:159184.
  • Altekruse, S. F., L. Huang, J. E. Cucinelli, T. S. McNeel, K. M. Wells, and M. N. Oliver 2010. Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999–2001. Cancer Epidemiology, Biomarkers & Prevention 19:14601467.
  • Alvarado, L. C. 2010. Population differences in the testosterone levels of young men are associated with prostate cancer disparities in older men. American Journal of Human Biology 22:449455.
  • Alvarado, L. C. 2011. Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparities. Ther Adv Urol 3:99106.
  • Andersson, S. O., H. O. Adami, R. Bergstrom, and L. Wide 1993. Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer—a population-based case-control study. British Journal of Cancer 68:97102.
  • Archer, J. 1991. The influence of testosterone on human aggression. British Journal of Psychology 82:128.
  • Archer, J. 2006. Testosterone and human aggression: an evaluation of the challenge hypothesis. Neuroscience and Biobehavioral Reviews 30:319345.
  • Banks, T., and J. M. Jr Dabbs 1996. Salivary testosterone and cortisol in a delinquent and violent urban subculture. Journal of Social Psychology 136:4956.
  • Barclay, G., C. Tavare, and A. Siddique 2001. International comparisons of criminal Justice statistics. Home Office for Statistical Research, no 6, London, U.K.
  • Beehner, J. C., T. J. Bergman, D. L. Cheney, R. M. Seyfarth, and P. L. Whitten 2006. Testosterone predicts future dominance rank and mating activity among male chacma baboons. Behavioral Ecology and Sociobiology 59:469479.
  • Bentley, G. R., A. M. Harrigan, B. Campbell, and P. T. Ellison 1993. Seasonal effects on salivary testosterone levels among lese males of the Ituri Forest, Zaire. American Journal of Human Biology 5:711717.
  • Bishop, D. T., A. W. Meikle, M. L. Slattery, J. D. Stringham, M. H. Ford, and D. W. West 1988. The effect of nutritional factors on sex hormone levels in male twins. Genetic Epidemiology 5:4359.
  • Bribiescas, R. G. 1996. Testosterone levels among Aché hunter-gatherer men. Human Nature 7:163188.
  • Bribiescas, R. G. 2001a. Reproductive ecology and life history of the human male. Yearb Phys Anthropol 44:148176.
  • Bribiescas, R. G. 2001b. Reproductive physiology of the human male: an evolutionary and life history perspective. In: P. Ellison, ed. Reproductive Ecology and Human Evolution, pp. 107135. Aldine de Gruyter, New York.
  • Campbell, B., M. T. O'Rourke, and S. F. Lipson 2003. Salivary testosterone and body composition among Ariaal males. American Journal of Human Biology 15:697708.
  • Campbell, B. C., P. B. Gray, D. T. Eisenberg, P. T. Ellison, and M. Sorenson 2007. Androgen receptor GAG repeats and body composition among Ariaal men. International Journal of Andrology 32:140148.
  • Carter, H. B., J. D. Pearson, E. J. Metter et al. 1995. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate 27:2531.
  • Cavigelli, S. A., and M. E. Pereira 2000. Mating season aggression and fecal testosterone levels in male ring-tailed lemurs (Lemur catta). Hormones and Behavior 37:246255.
  • Centers for Disease Control and Prevention and National Cancer Institute. 2012. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2008 Incidence and Mortality Web-based Report. U.S. Department of Health and Human Services, Atlanta. Available at: www.cdc.gov/uscs.
  • Chisholm, J.S. 1993. Death, hope, and sex: Life history theory and the development of reproductive strategies. Current Anthropology 34:124.
  • Christiansen, K. H. 1991. Serum and saliva sex hormone levels in !Kung San men. American Journal of Physical Anthropology 86:3744.
  • Clutton-Brock, T. H., and G. A. Parker 1992. Potential Reproductive Rates and the Operation of Sexual Selection. The Quarterly Review of Biology 674:437456.
  • Clutton-Brock, T. H., and A. C. J. Vincent 1991. Sexual selection and the potential reproductive rates of males and females. Nature 351:5860.
  • Curado, M. P., B. Edwards, H. R. Shin, eds. et al. 2007. Cancer Incidence in Five Continents, Vol. IX. IARC. IARC Scientific Publications No. 160, Lyon.
  • Dabbs, J. M. Jr 1992. Testosterone and occupational achievement. Social Forces 70:813824.
  • Dabbs, J. M. Jr, and R. Morris 1990. Testosterone, Social Class, and Antisocial Behavior in a Sample of 4,462 Men. Psychological Science 1:209211.
    Direct Link:
  • Dabbs, J. M. Jr, G. J. Jurkovic, and R. L.Frady 1991. Salivary testosterone and cortisol among late adolescent male offenders. Journal of Abnormal Child Psychology 19:469478.
  • Dabbs, J. M. Jr, E. C. Alford, and J. A. Fielden 1998. Trial lawyers and testosterone: blue-collar talent in a white-collar world. Journal of Applied Social Psychology 28:8494.
  • Demers, P. A., H. Checkoway, T. L. Vaughan, N. S. Weiss, N. J. Heyer, and L. Rosenstock 1994. Cancer Incidence among Firefighters in Seattle and Tacoma, Washington (United States). Cancer Causes and Control 5:129135.
  • Du, X. L., S. Fang, A. L. Coker et al. 2006. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 106:12761285.
  • Eaton, S. B., B. I. Strassman, R. M. Nesse, J. V. Neel, P. W. Ewald, G. C. Williams et al. 2002. Evolutionary health promotion. Preventive Medicine 34:109118.
  • Elia, M. 1992. Energy expenditure to metabolic rate. In: J. M. McKinney, and H. N. Tucker, eds. Energy metabolism: tissue determinants and cellular corollaries, pp. 1949. Raven Press, NewYork.
  • Ellis, L., and H. Nyborg 1992. Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids 57:7275.
  • Ellison, P. T. 1988. Human salivary steroids: methodological issues and applications in physical anthropology. Yrb Phys Anthropol 31:115142.
  • Ellison, P. T., and C. Panter-Brick 1996. Salivary testosterone levels among Tamang and Kami males of central Nepal. Human Biology 68:955965.
  • Ellison, P. T., S. F. Lipson, and M. D. Meredith 1989. Salivary testosterone levels in males from the Ituri forest of Zaire. American Journal of Human Biology 1:2124.
  • Ellison, P. T., R. G. Bribiescas, G. R. Bentley et al. 2002. Population variation in age-related decline in male salivary testosterone. Human Reproduction 17:32513253.
  • Ettinger, B., S. Sidney, S. R. Cummings, C. Libanati, D. D. Bikle, I. S. Tekawa, et al. 1997. Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. Journal of Clinical Endocrinology and Metabolism 82:429434.
  • Field, A. E., G. A. Colditz, W. C. Willett, C. Longcope, and J. B. McKinlay 1994. The relation of smoking, age, relative weight and dietary intake to serum adrenal steroids, sex hormones and sex hormone-binding globulin in middle-aged men. Journal of Clinical Endocrinology and Metabolism 79:13101316.
  • Fleming, A. S., C. Corter, J. Stallings, and M. Steiner 2002. Testosterone and prolactin are associated with emotional responses to infant cries in new fathers. Hormones and Behavior 42:399413.
  • Gadgil, M., and W. H. Bossert 1970. Life historical consequences of natural selection. American Naturalist 104:124.
  • Gann, P. H., C. H. Hennekens, J. Ma, C. Longcope, and M. J. Stampfer 1996. Prospective study of sex hormone levels and risk of prostate cancer. Journal of the National Cancer Institute 88:11181126.
  • Gapstur, S. M., P. H. Gann, P. Kopp, L. Colangelo, C. Longcope, and K. Liu. 2002. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiology, Biomarkers & Prevention 11:10411047.
  • Geary, D. C. 2005. Evolution of paternal investment. In: D. M. Buss, ed. The evolutionary psychology handbook, pp. 483505. John Wiley & Sons, Hoboken, NJ.
  • Geronimus, A. T. 1996. What teen mother know. Human Nature 7:323352.
  • Geronimus, A. T., J. Bound, T. A. Waidmann, M. M. Hillemeier, and P. B. Burns 1996. Excess mortality among blacks and whites in the United States. New England Journal of Medicine 335:15521558.
  • Geronimus, A. T., J. Bound, and T. A. Waidmann 1999. Poverty, time, and place: variation in excess mortality across selected US populations, 1980–1990. Journal of Epidemiology and Community Health 53:325334.
  • Gettler, L. T., S. S. Agustin, and C. W. Kuzawa 2010. Testosterone, physical activity, and somatic outcomes among Filipino males. American Journal of Physical Anthropology 142:590599.
  • Gettler, L. T., T. W. McDade, A. B. Feranil, and C. W. Kuzawa 2011. Longitudinal evidence that fatherhood decreases testosterone in human males. Proceedings of the National Academy of Sciences of the United States of America 108:1619416199.
  • Ghafoor, A., A. Jemal, V. Cokkinides, C. Cardinez, T. Murray, A. Samuels, and M. J. Thun 2002. Cancer Statistics for African Americans. CA: A Cancer Journal for Clinicians 52:326341.
  • Giagulli, V. A., L. Verdonck, R. Giorgino, and A. Vermeulen 1989. Precursors of plasma androstanediol- and androgen-glucuronides in women. Journal of Steroid Biochemistry and Molecular Biology 33:935940.
  • Giagulli, V. A., J. M. Kaufman, and A. Vermeulen 1994. Pathogenesis of the decreased androgen levels in obese men. Journal of Clinical Endocrinology and Metabolism 79:9971000.
  • Giovannucci, E., M. J. Stampfer, K. Krithivas, M. Brown, D. Dahl, A. Brufsky et al. 1997. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 94:33203323.
  • Gray, P. B. 2003. Marriage, parenting, and testosterone variation among Kenyan Swahili men. American Journal of Physical Anthropology 122:279286.
  • Gray, A., J. A. Berlin, J. B. McKinlay, and C. Longcope 1991. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. Journal of Clinical Epidemiology 44:671684.
  • Gray, P. B., S. M. Kahlenberg, E. S. Barrett, S. F. Lipson, and P. T. Ellison 2002. Marriage and fatherhood are associated with lower testosterone in males. Evolution and Human Behavior 23:193201.
  • Gray, P. B., A. Kruger, H. W. Huisman, M. P. Wissing, and H. H. Vorster 2006a. Predictors of South African male testosterone levels: the THUSA study. American Journal of Human Biology 18:123132.
  • Gray, P. B., C. F. Yang, and H. G. Jr Pope 2006b. Fathers have lower salivary testosterone levels than unmarried men and married non-fathers in Beijing. Proceedings. Biological sciences/The Royal Society 273:333339.
  • Grönberg, H. 2003. Prostate cancer epidemiology. Lancet 361:859864.
  • Häkkinen, K., and A. Pakarinen 1993. Muscle strength and serum testosterone, cortisol and SHBG concentrations in middle-aged and elderly men and women. Acta Physiologica Scandinavica 148:199207.
  • Hall, S. E., C. D. J. Holman, Z. S. Wisniewski, and J. Semmens 2005. Prostate cancer: socio-economic, geographical and private-health insurance effects on care and survival. BJU International 95:5158.
  • Hamilton, J. B., and G. E. Mestler 1969. Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. Journal of Gerontology 24:395411.
  • Heald, A. H., F. Ivison, S. G. Anderson, K. Cruickshank, I. Laing, and J. M. Gibson 2003. Significant ethnic variation in total and free testosterone concentration. Clinical Endocrinology 58:262266.
  • Henderson, B. E., R. K. Ross, M. C. Pike, and J. T. Casagrande 1982. Endogenous hormones as a major factor in human cancer. Cancer Research 42:32323239.
  • Hill, K. 1993. Life History Theory and Evolutionary Anthropology. Evolutionary Anthropology 2:7888.
  • Holden, C. 1987. Why do women live longer than men? Science 238:158160.
  • Howlader, N., A. M. Noone, M. Krapcho, N. Neyman, R. Aminou, S. F. Altekruse, C. L. Kosary et al. (eds). 2012. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2012.
  • Hsing, A. W. 2001. Hormones and prostate cancer: what's next? Epidemiologic Reviews 23:4258.
  • Hsing, A. W., and A. P. Chokkalingam 2006. Prostate cancer epidemiology. Frontiers in Bioscience 11:13881413.
  • Hsing, A. W., and G. W. Comstock 1993. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 2:2732.
  • Hsing, A. W., L. Tsao, and S. S. Devesa 2000. International trends and patterns of prostate cancer incidence and mortality. International Journal of Cancer 85:6067.
  • Hsing, A. W., L. W. Chu, and F. Z. Stanczyk 2008. Androgen and prostate cancer: is the hypothesis dead? Cancer Epidemiology, Biomarkers & Prevention 17:25252530.
  • Huggins, C., and C. V. Hodges 1941. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research 1:293297.
  • Irvine, R. A., M. C. Yu, R. K. Ross, and G. A. Coetzee 1995. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Research 55:19371940.
  • Jakobsson, J., L. Ekstrom, N. Inotsume et al. 2006. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. Journal of Clinical Endocrinology and Metabolism 91:687693.
  • Jankowska, E. A., R. Rogucka, M. Medras, and Z. Welon 2000. Relationships between age-related changes of sex steroids, obesity and body fat distribution among healthy Polish males. Medical Science Monitor 6:11591164.
  • Jensen, T. K., A.-M. Andersson, N. Jørgensen, A.-G. Andersen, E. Carlsen, Petersen JøH et al. 2004. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertility and Sterility 82:863870.
  • Jin, B., L. Turner, W. A. W. Walters, and D. J. Handelsman 1996. Androgen or estrogen effects on human prostate. Journal of Clinical Endocrinology and Metabolism 81:42904295.
  • Jin, B., J. Beilin, J. Zajac, and D. J. Handelsman 2000. Androgen receptor gene polymorphism and prostate zonal volumes in Australian and Chinese men. Journal of Andrology 21:9198.
  • de Jong, F. H., K. Oishi, R. B. Hayes et al. 1991. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. Cancer Research 51:34453450.
  • Kamangar, F., G. M. Dores, and W. F. Anderson 2006. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Journal of Clinical Oncology 24:21372150.
  • Kaplan, H., K. Hill, J. B. Lancaster, and M. Hurtado 2000. A Theory of Human Life History Evolution: diet, Intelligence, and Longevity. Evolutionary Anthropology 9:156185.
  • Kapoor, P., B. M. Luttrell, and D. Williams 1993. The free androgen index is not valid for adult males. Journal of Steroid Biochemistry and Molecular Biology 45:325326.
  • Kehinde, E. O., A. O. Akanji, A. Memon et al. 2006. Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. International Urology and Nephrology 38:3344.
  • Ketterson, E. D., and V. Jr Nolan 1992. Hormones and life histories: an integrative approach. Am Nat 140(Suppl):S33S62.
  • Key, T. J., L. Roe, M. Thorogood, J. W. Moore, G. M. Clark, and D. Y. Wang 1990. Testosterone, sex hormone-binding globulin, calculated free testosterone, and oestradiol in male vegans and omnivores. British Journal of Nutrition 64:111119.
  • Kley, H. K., T. Deselaers, H. Peerenboom, and H. L. Krüskemper 1980. Enhanced conversion of androstenedione to estrogens in obese males. Journal of Clinical Endocrinology and Metabolism 51:11281132.
  • Kley, H. K., T. Deselaers, and H. Peerenboom 1981. Evidence for hypogonadism in massively obese males due to decreased free testosterone. Hormone and Metabolic Research 13:639641.
  • Klibanski, A., I. Z. Beitins, T. Badger, R. Little, and J. W. McArthur 1981. Reproductive function during fasting in men. Journal of Clinical Endocrinology and Metabolism 53:258263.
  • Kolonel, L. N. 2001. Fat, meat, and prostate cancer. Epidemiologic Reviews 23:7281.
  • Kovi, J., and M. Y. Heshmat 1972. Incidence of cancer in negroes in Washington, D.C. and selected African cities. American Journal of Epidemiology 96:401413.
  • Krause, W. 2006. Androgens in the demography of male life course - A review. Social Biology 53:412.
  • Kubricht, W. S. 3rd, B. J. Williams, T. Whatley, P. Pinckard, and J. A. Eastham 1999. Serum testosterone levels in African-American and white men undergoing prostate biopsy. Urology 54:10351038.
  • Lado-Abeal, J., D. Prieto, M. Lorenzo, S. Lojo, M. Febrero, E. Camarero, and J. Cabezas-Cerrato 1999. Differences between men and women as regards the effects of protein-energy malnutrition on the hypothalamic-pituitary-gonadal axis. Nutrition 15:351358.
  • Lancaster, J. B., and C. S. Lancaster. 1983. Parental Investment: The Hominid Adaptation.In D. Ortner, Ed. How Humans Adapt: A Biocultural Odyssey, Proceedings of the Seventh International Smithsonian Symposium, pp. 3366. Smithsonian Institution. Washington.
  • Leroy, B. E., and N. Northrup 2009. Prostate cancer in dogs: comparative and clinical aspects. Veterinary Journal 180:149162.
  • Lipson, S. F., and P. T. Ellison 1989. Development of protocols for the application of salivary steroid analyses to field conditions. American Journal of Human Biology 1:249255.
  • Lukas, W.D., B. C. Campbell, and P. T. Ellison 2004. Testosterone, aging, and body composition in men from Harare, Zimbabwe. American Journal of Human Biology 16:704712.
  • Lund-Nilsen, T. I., R. Johnsen, and L. J. Vatten 2000. Socio-economic and lifestyle factors associated with the risk of prostate cancer. British Journal of Cancer 82:13581363.
  • Mather, M. 2010. U.S. Children in single mother-families. Population Reference Burea. Data Brief. May, Washington, D.C.
  • Matsumoto, A. M. 2001. The testis. In: F. Felig, and L. A. Frohman, eds. Endocrinology and Metabolism. 4th edn, p. 635706. McGraw-Hill Professional, New York.
  • Mazur, A. 1995. Biosocial models of deviant behavior among male army veterans. Biological Psychology 41:271293.
  • Mazur, A. 2006. The role of testosterone in male dominance contests that turn violent. Social Biology 53:2429.
  • Meikle, A. W., and W. M. Stanish 1982. Familial prostatic cancer risk and low testosterone. Journal of Clinical Endocrinology and Metabolism 54:11041108.
  • Merrill, R. M., and M. K. Morris 2002. Prevalence-corrected prostate cancer incidence rates and trends. American Journal of Epidemiology 155:148152.
  • Miyamoto, H., E. M. Messing, and C. Chang 2004. Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate 61:332353.
  • Mohler, J. L. 2007. Racial Differences in Prostate Cancer Mortality. In L. W. K. Chung, W. B. Isaacs, and J. W. Simons eds. Contemporary Cancer Research: Prostate Cancer: Biology, Genetics, and the New Therapeutics, (2nd Edition). pp. 355376. Humana Press Inc., Totowa, NJ
  • Morley, J. E., P. Patrick, and H. M. III Perry 2002. Evaluation of assays available to measure free testosterone. Metabolism 51:554559.
  • Morris, P. D., C. J. Malkin, K. S. Channer, and T. H. Jones 2004. A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. European Journal of Endocrinology 15:241249.
  • Muehlenbein, M. P. 2008. Adaptive variation in testosterone levels in response to immune activation: empirical and theoretical perspectives. Social Biology 53:1323.
  • Muehlenbein, M. P., and R. G. Bribiescas 2005. Testosterone-mediated immune functions and male life histories. American Journal of Human Biology 17:527558.
  • Muehlenbein, M. P., D. P. Watts, and P. L. Whitten 2004. Dominance rank and fecal testosterone levels in adult male chimpanzees (Pan troglodytes schweinfurthii) at Ngogo, Kibale National Park, Uganda. American Journal of Primatology 64:7182.
  • Muller, M. N., and R. W. Wrangham 2004. Dominance, aggression and testosterone in wild chimpanzees: a test of the ‘challenge hypothesis’. Animal Behaviour 67:113123.
  • Muller, M. N., and R. W. Wrangham 2005. Testosterone and energetics in wild chimpanzees (Pan troglodytes schweinfurthii). American Journal of Primatology 66:119130.
  • Muller, M. N., F. W. Marlowe, R. Bugumba, and P. T. Ellison 2009. Testosterone and paternal care in East African foragers and pastoralists. Proceedings. Biological sciences/The Royal Society 276:347354.
  • Odedina, F. T., J. O. Ogunbiyi, and F. A. Ukoli 2006. Roots of prostate cancer in African-American men. Journal of the National Medical Association 98:539543.
  • O'Malley, B. W. 1971. Mechanism of action of steroid hormones. New England Journal of Medicine 284:370377.
  • Parsons, J. K., H. B. Carter, E. A. Platz, E. J. Wright, P. Landis, and J. Metter 2005. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiology, Biomarkers & Prevention 14:22572260.
  • Pettaway, C. A. 1999. Racial differences in the androgen/androgen receptor pathway in prostate cancer. Journal of the National Medical Association 91:653660.
  • Platz, E. A., and E. Giovannucci 2004. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 92:237253.
  • Pollard, M. M., P. P. H. Luckert, and M. M. A. Schmidt 1982. Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate 3:563568.
  • Pritchard, J., J. P. Després, J. Gagnon et al. 1998. Plasma adrenal, gonadal, and conjugated steroids before and after long-term overfeeding in identical twins. Journal of Clinical Endocrinology and Metabolism 83:32773284.
  • Rapiti, E., G. Fioretta, R. Schaffar, I. Neyroud-Caspar, H. M. Verkooijen, F. Schmidlin et al. 2009. Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis. Cancer 115:55565565.
  • Redpath, S. M., F. Mougeot, F. M. Leckie, and S. A. Evans 2006. The effects of autumn testosterone on survival and productivity in red grouse, Lagopus lagopus scoticus. Animal Behaviour 71:12971305.
  • Ringel, C. 1997. Criminal victimization in 1996. Changes 1995-96 with trends 1993-96, NCJ-165812: 1997. Bureau of Justice Statistics, U.S. Department of Justice, Washington D. C.
  • Roddam, A. W., N. E. Allen, P. Appleby, T. J. Key et al. 2008. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. Journal of the National Cancer Institute 100:170183.
  • Rohrmann, S., W. G. Nelson, N. Rifai et al. 2007. Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. Journal of Clinical Endocrinology and Metabolism 92:25192525.
  • Rosner, W., R. J. Auchus, R. Azziz, P. M. Sluss, and H. Raff 2007. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism 92:405413.
  • Ross, R., L. Bernstein, H. Judd, R. Hanisch, M. Pike, and B. Henderson 1986. Serum testosterone levels in healthy young black and white men. Journal of the National Cancer Institute 76:4548.
  • Ross, R. K., L. Bernstein, R. A. Lobo et al. 1992. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339:887889.
  • Ross, R. K., M. C. Pike, G. A. Coetzee, J. K. Reichardt, M. C. Yu, H. Feigelson et al. 1998. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Research 58:44974504.
  • Sachs, J. D. 2006. Welfare states beyond ideology. Scientific American 295:42.
  • Sampson, R., and W. Wilson 1995. Toward a theory of race, crime, and urban inequality. In: J. Hagan, and R. Peterson, eds. Crime and Inequality, pp. 3754. Stanford University Press, Stanford, CA.
  • Sanderson, M., A. Coker, A. Perez, X. Du, G. Peltz, and M. Fadden 2006. A multilevel analysis of socioeconomic status and prostate cancer risk. Annals of Epidemiology 16:901907.
  • Santner, S. J., B. Albertson, G.-Y. Zhang et al. 1998. Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. Journal of Clinical Endocrinology and Metabolism 83:21042109.
  • Sartor, O., Q. Zheng, and J. A. Eastham 1999. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer. Urology 53:378380.
  • Severson, R. K., A. M. Y. Nomura, J. S. Grove, and G. N. Stemmerman 1989. A Prospective Study of Demographics, Diet, and Prostate Cancer among Men of Japanese Ancestry in Hawaii. Cancer Research 49:18571860.
  • Shaneyfelt, T., R. Husein, G. Bubley, and C. S. Mantzoros 2000. Hormonal predictors of prostate cancer: a meta-analysis. Journal of Clinical Oncology 18:847853.
  • Shibata, A., A. S. Whittemore, K. Imai et al. 1997. Serum levels of prostate-specific antigen among Japanese-American and native Japanese men. Journal of the National Cancer Institute 89:17161720.
  • Simmons, Z. L., and J. R. Roney 2009. Androgens and energy allocation: quasi-experimental evidence for effects of influenza vaccination on men's testosterone. American Journal of Human Biology 21:133135.
  • Singh, G. K. B. A. Miller, B. F. Hankey, and B. K. 2003. Edwards. Area Socioeconomic Variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975–1999. NCI Cancer Surveillance Monograph Series, Number 4. Bethesda, MD: National Cancer Institute, 2003. NIH Publication No. 03-5417.
  • Smith, G. D., J. D. Neaton, D. Wentworth, R. Stamler, and J. Stamler 1996a. Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: I. White men. American journal of public health 86:486496.
  • Smith, G. D., J. D. Neaton, D. Wentworth, R. Stamler, and J. Stamler 1996b. Socioeconomic differentials in mortality risk among men screened for the multiple risk factor intervention trial: II. Black men. American Journal of Public Health 86:497504.
  • Smith, C. M., S. A. Ballard, M. G. Wyllie, and J. R. Masters. 1994. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro. Journal of Steroid Biochemistry and Molecular Biology 50:151159.
  • Sofikerim, M., S. Eskicorapci, O. Oruç, and H. Ozen 2007. Hormonal predictors of prostate cancer. Urologia Internationalis 79:1318.
  • Stearns, S. C. 1989. Trade-Offs in Life-History Evolution. Functional Ecology 3:259268.
  • Strauss, R. H., R. R. Lanese, and W. B. Malarkey 1985. Weight loss in amateur wrestlers and its effect on serum testosterone levels. JAMA 254:33373338.
  • Thompson, I. M., P. J. Goodman, C. M. Tangen, M. S. Lucia, G. J. Miller, L. G. Ford et al. 2003. The influence of finasteride on the development of prostate cancer. New England Journal of Medicine 349:215224.
  • Tomova, A., and P. Kumanov 1999. Sex differences and similarities of hormonal alterations in patients with anorexia nervosa. Andrologia 31:143147.
  • Trivers, R. L. 1972. Parental investment and sexual selection. In: B. Campbell, ed. Sexual selection and the descent of man: 1871–1971, pp. 136179. Aldine, Chicago.
  • Trumble, B. C., E. Brindle, M. Kupsik, and K. A. O'Connor 2010. Responsiveness of the reproductive axis to a single missed evening meal in young adult males. American Journal of Human Biology 22:775781.
  • Tsai, C. J., B. A. Cohn, P. M. Cirillo, D. Feldman, F. Z. Stanczyk, and A. S. Whittemore 2006. Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States). Cancer Causes and Control 17:12371244.
  • Uchida, A., R. G. Bribiescas, P. T. Ellison et al. 2006. Age related variation of salivary testosterone values in healthy Japanese males. The aging male 9:207213.
  • United Nations Development Programme 2000. Human Development Report 2000: human rights and human development. Oxford University Press, Inc., New York.
  • Vermeulen, A., L. Verdonck, and J. M. Kaufman 1999. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 84:36663672.
  • Vittek, J., D. G. L'Hommedieu, G. G. Gordon, S. C. Rappaport, and A. L. Southren 1985. Direct radioimmunoassay (RIA) of salivary testosterone: correlation with free and total serum testosterone. Life Sciences 37:711716.
  • Western, B. 2002. The Impact of Incarceration on Wage Mobility and Inequality. American Sociological Review 67:526546.
  • Wilson, M., and M. Daly 1985. Competitiveness, risk taking, and violence: the young male syndrome. Ethology and Sociobiology 6:5973.
  • Wingfield, J. C., R. E. Hegner, A. M. Dufty, and G. F. Ball 1990. The “Challenge Hypothesis”: theoretical implications for patterns of testosterone secretion, mating systems, and breeding strategies. Am Nat 136:829846.
  • Winters, S. J., A. Brufsky, J. Weissfeld, and D. L. Trump 2001. Dyky MA, Hadeed V. Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 50:12421247.
  • Wolk, A., S. O. Andersson, and R. Bergström 1997. Re: prospective study of sex hormone levels and risk of prostate cancer. Journal of the National Cancer Institute 89:820.
  • Woodhouse, L. J., S. Reisz-Porszasz, M. Javanbakht, T. W. Storer, M. Lee, H. Zerounian et al. 2003. Development of models to predict anabolic response to testosterone administration in healthy young men. American journal of physiology. Endocrinology and metabolism 284:E1009E1017.
  • World Health Organization 2002. The European Health Report. European series: No. 97. World Health Organization Regional Publications, Copenhagen, Denmark.
  • Yu, H., R. E. Harris, Y. T. Goa, and E. L. Wynder 1991. Comparative epidemiology of cancers of the colon, rectum, prostate, and breast in Shanghai, China, vs. the United States. International Journal of Epidemiology 20:7681.
  • Zahavi, A. 1975. Mate selection - a selection for a handicap. Journal of Theoretical Biology 53:205214.
  • Zeegers, M. P. A., I. H. M. Friesema, R. A. Goldbohm, and P. A. van den Brandt 2004. A prospective study of occupation and prostate cancer risk. Journal of Occupational and Environmental Medicine 46:271279.

Appendix :: Testosterone Measures

  1. Top of page
  2. Abstract
  3. Introduction
  4. Part 1: Elevated testosterone as a risk factor for prostate cancer
  5. Part 2: Life-history trade-offs affecting reproductive physiology
  6. Part 3: Biosocial influences on testosterone production
  7. Part 4: The challenge hypothesis and prostate cancer risk
  8. Discussion
  9. Acknowledgements
  10. Literature cited
  11. Appendix :: Testosterone Measures

The following overview will distinguish between different measurements of endogenous testosterone and will describe the functional significance of these measures. Men's serum total and free testosterone levels are frequently reported in the literature. Free steroid molecules are able to diffuse across cell membranes to interact with endocellular receptors and produce transcriptional activity that promotes androgenic signaling. However, free steroids are hydrophobic and must bind to carrier proteins for transport in peripheral circulation, such that only a small fraction of testosterone circulates in free form (Matsumoto 2001).

Serum testosterone is bound primarily to two carrier proteins, sex hormone binding globulin (SHBG) and albumin. Albumin binds loosely to testosterone, and albumin-bound testosterone is able to dissociate from its bond for entry into target tissues. SHBG, unlike albumin, binds testosterone with high affinity, rendering the molecule biologically inactive (Matsumoto 2001). Because total testosterone is a cumulative measure of diffusible and protein-bound testosterone, free testosterone is generally regarded as a more direct assessment of physiological availability (Matsumoto 2001; Rosner et al. 2007).

The literature also reports estimates of physiologically available testosterone, such as ‘bioavailable’ testosterone and free androgen index (FAI). Bioavailable testosterone is the combined portion of free and albumin-bound testosterone, whereas FAI is the quotient of total testosterone concentration/SHBG concentration (Rosner et al. 2007). Bioavailable testosterone correlates well with free testosterone (Vermeulen et al. 1999; Morley et al. 2002; Morris et al. 2004; Rosner et al. 2007), but FAI has shown poor correlations with free testosterone, particularly in men (Kapoor et al. 1993; Morris et al. 2004). Because of FAI's inconsistency, I relied on reports that used more dependable measures of serum testosterone: total, free, and bioavailable. In addition to serum, free testosterone levels can be collected from saliva (Ellison 1988; Lipson and Ellison 1989) as well as testosterone glucuronide excreted in urine and deconjugated for analysis (Muller and Wrangham 2004). Testosterone concentration in saliva is determined using radioimmunoassay procedures (Ellison 1988), and salivary testosterone levels are significantly correlated with serum-free testosterone levels (Vittek et al. 1985). Hormone analysis protocols used to assay salivary testosterone have also been adapted for urine (Muller and Wrangham 2004). These methods of noninvasive steroid hormone collection and analysis have proved invaluable for field research conducted outside of a laboratory setting.